Cactus Life Sciences Top 5 Trends of 2024

Cactus Life Sciences’ Top 5 Trends of 2024: Insights Driving Tomorrow’s MedComms

Here, we revisit our most thought-provoking articles and whitepapers, each addressing pivotal trends that influence the ever-evolving biopharma landscape...
Read More

Top Stories

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to

Engagement with Medical Affairs is critical at every...
Leverage Social Media to Transform Medical Affairs | Promoting Disease Awareness, Ensuring Compliance and Assessing Outcomes

Leveraging Social Media to Transform Medical

This whitepaper explores the role of social media in...
HCP engagement

A 4-Step Plan to Drive HCP Engagement

HCPs are a time-constrained and hard-to-engage audience. Learn how pharma can digitally engage HCPs better...
diversity and inclusion

Promoting Diversity and Inclusion in Clinical Trials – New England Journal of Medicine’s New Policy

Read this update on how the New England Journal of Medicine is trying to promote...

MedTech Summit 2021: Understanding Post Market Clinical Follow Up (PCMF)

An ideal PMCF plan, with reference to MDCG 2020-7, presents the general and specific methods...

Bringing New Devices to Market under the EU MDR

With the MDR coming into effect, the manufacturers should plan and construct their strategy to...
Clinical Trial Pain Points

Pharma, Physician, and Patient Pain Points Regarding Clinical Trials

Pharma, physicians, and patients consistently face challenges related to clinical trials. Here's a quick look...
FINAL Clinical Trial Summaries Blog-Banner-810x540

Clinical Trial Summaries – What Are They and Why Do They Matter for Pharma?

A majority of patients feel lay summaries for clinical trials are very important and won’t...

Learn more ABOUT our company.